Cigna (CI) Cash & Equivalents (2017 - 2026)

Cigna (CI) has 10 years of Cash & Equivalents data on file, last reported at $7.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 15.53% year-over-year to $7.0 billion; the trailing twelve-month figure through Mar 2026 stood at $7.0 billion (down 15.53% YoY), and the FY2025 full-year result was $7.7 billion, up 1.67% from the prior year.
• Cash & Equivalents retreated to $7.0 billion in Q1 2026, from $7.7 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $9.6 billion in Q2 2023 to a low of $4.3 billion in Q2 2025.
• A 5-year average of $6.9 billion and a median of $7.1 billion in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 116.81% in 2023 and plunged 36.23% in 2025, its largest moves.
• Tracing CI's Cash & Equivalents over 5 years: stood at $5.9 billion in 2022, then jumped by 32.04% to $7.8 billion in 2023, then slipped by 3.48% to $7.6 billion in 2024, then climbed by 1.67% to $7.7 billion in 2025, then retreated by 8.29% to $7.0 billion in 2026.
• Business Quant data shows CI's Cash & Equivalents at $7.0 billion in Q1 2026, $7.7 billion in Q4 2025, and $6.0 billion in Q3 2025.